MERCK Kommanditgesellschaft auf Aktien (MRK.DE)
EUR 119.8
(-0.66%)
EUR 119.8
(-0.66%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 8.84 Billion EUR | -3.85% |
| 2022 | 9.2 Billion EUR | 11.25% |
| 2021 | 8.27 Billion EUR | -15.14% |
| 2020 | 9.74 Billion EUR | 13.49% |
| 2019 | 8.58 Billion EUR | 29.97% |
| 2018 | 6.6 Billion EUR | -16.85% |
| 2017 | 7.94 Billion EUR | -8.72% |
| 2016 | 8.7 Billion EUR | -8.49% |
| 2015 | 9.51 Billion EUR | 167.12% |
| 2014 | 3.56 Billion EUR | 9.32% |
| 2013 | 3.25 Billion EUR | 0.55% |
| 2012 | 3.23 Billion EUR | 0.0% |
| 2011 | - EUR | 0.0% |
| 2010 | - EUR | 0.0% |
| 2009 | - EUR | 0.0% |
| 2008 | - EUR | 0.0% |
| 2007 | - EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| 2004 | - EUR | 0.0% |
| 2003 | - EUR | 0.0% |
| 2002 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 7.31 Billion EUR | -8.22% |
| 2024 Q1 | 7.82 Billion EUR | -11.56% |
| 2023 FY | 8.84 Billion EUR | -3.85% |
| 2023 Q4 | 8.84 Billion EUR | -7.27% |
| 2023 Q3 | 9.54 Billion EUR | 0.47% |
| 2023 Q1 | 9.15 Billion EUR | -0.45% |
| 2023 Q2 | 9.49 Billion EUR | 3.67% |
| 2022 Q3 | 9.26 Billion EUR | -1.27% |
| 2022 FY | 9.2 Billion EUR | 11.25% |
| 2022 Q2 | 9.38 Billion EUR | 13.26% |
| 2022 Q1 | 8.28 Billion EUR | 0.19% |
| 2022 Q4 | 9.2 Billion EUR | -0.71% |
| 2021 Q2 | 8.72 Billion EUR | -3.11% |
| 2021 Q4 | 8.27 Billion EUR | 0.92% |
| 2021 Q3 | 8.19 Billion EUR | -6.03% |
| 2021 FY | 8.27 Billion EUR | -15.14% |
| 2021 Q1 | 9 Billion EUR | -7.63% |
| 2020 Q2 | 10.08 Billion EUR | -0.55% |
| 2020 Q1 | 10.13 Billion EUR | 18.05% |
| 2020 Q3 | 9.97 Billion EUR | -1.03% |
| 2020 Q4 | 9.74 Billion EUR | -2.33% |
| 2020 FY | 9.74 Billion EUR | 13.49% |
| 2019 Q4 | 8.58 Billion EUR | -0.31% |
| 2019 Q1 | 5.04 Billion EUR | -23.61% |
| 2019 Q2 | 6.49 Billion EUR | 28.73% |
| 2019 Q3 | 8.61 Billion EUR | 32.58% |
| 2019 FY | 8.58 Billion EUR | 29.97% |
| 2018 FY | 6.6 Billion EUR | -16.85% |
| 2018 Q1 | 7.93 Billion EUR | -0.13% |
| 2018 Q2 | 8.09 Billion EUR | 1.94% |
| 2018 Q3 | 7.09 Billion EUR | -12.3% |
| 2018 Q4 | 6.6 Billion EUR | -6.88% |
| 2017 Q1 | 8.36 Billion EUR | -3.94% |
| 2017 Q4 | 7.94 Billion EUR | -1.5% |
| 2017 Q3 | 8.06 Billion EUR | -1.04% |
| 2017 Q2 | 8.15 Billion EUR | -2.51% |
| 2017 FY | 7.94 Billion EUR | -8.72% |
| 2016 Q4 | 8.7 Billion EUR | 1.4% |
| 2016 Q3 | 8.58 Billion EUR | -7.59% |
| 2016 Q2 | 9.29 Billion EUR | 0.31% |
| 2016 FY | 8.7 Billion EUR | -8.49% |
| 2016 Q1 | 9.26 Billion EUR | -2.64% |
| 2015 Q2 | 6.87 Billion EUR | -4.85% |
| 2015 Q3 | 9.15 Billion EUR | 33.14% |
| 2015 Q1 | 7.22 Billion EUR | 102.99% |
| 2015 FY | 9.51 Billion EUR | 167.12% |
| 2015 Q4 | 9.51 Billion EUR | 3.88% |
| 2014 FY | 3.56 Billion EUR | 9.32% |
| 2014 Q2 | 1.93 Billion EUR | 1.03% |
| 2014 Q1 | 1.91 Billion EUR | -41.14% |
| 2014 Q4 | 3.56 Billion EUR | 64.77% |
| 2014 Q3 | 2.16 Billion EUR | 11.57% |
| 2013 Q1 | 3.36 Billion EUR | 3.88% |
| 2013 FY | 3.25 Billion EUR | 0.55% |
| 2013 Q4 | 3.25 Billion EUR | -0.52% |
| 2013 Q3 | 3.27 Billion EUR | -0.87% |
| 2013 Q2 | 3.3 Billion EUR | -1.85% |
| 2012 Q3 | 3.38 Billion EUR | 0.0% |
| 2012 Q4 | 3.23 Billion EUR | -4.18% |
| 2012 FY | 3.23 Billion EUR | 0.0% |
| 2012 Q1 | - EUR | 0.0% |
| 2012 Q2 | - EUR | 0.0% |
| 2011 Q3 | - EUR | 0.0% |
| 2011 FY | - EUR | 0.0% |
| 2011 Q1 | - EUR | 0.0% |
| 2011 Q2 | - EUR | 0.0% |
| 2011 Q4 | - EUR | 0.0% |
| 2010 Q2 | - EUR | 0.0% |
| 2010 Q1 | - EUR | 0.0% |
| 2010 FY | - EUR | 0.0% |
| 2010 Q4 | - EUR | 0.0% |
| 2010 Q3 | - EUR | 0.0% |
| 2009 FY | - EUR | 0.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2008 FY | - EUR | 0.0% |
| 2007 FY | - EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| 2004 FY | - EUR | 0.0% |
| 2003 FY | - EUR | 0.0% |
| 2002 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| MPH Health Care AG | 8.33 Million EUR | -106052.004% |
| Apontis Pharma AG | 6 Million EUR | -147333.333% |
| Dermapharm Holding SE | 950.7 Million EUR | -830.467% |
| Evotec SE | 477.11 Million EUR | -1754.072% |
| PharmaSGP Holding SE | 65.37 Million EUR | -13432.201% |
| SynBiotic SE | 2.89 Million EUR | -305625.528% |